Where does Zense-Life Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Zense-Life Inc. ranks #38,425 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Zense-Life Inc. hold?

Zense-Life Inc. holds 7 US utility patents granted between 2021 and 2023, spanning 8 technology areas.

What is Zense-Life Inc.'s Innovation Score?

Zense-Life Inc. has an Innovation Score of 44.0 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Zense-Life Inc. focus on?

Zense-Life Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 7 patents, ranking #2,341 of 7,127 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Zense-Life Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Zense-Life Inc..

What does claim depth mean for Zense-Life Inc.'s patents?

Zense-Life Inc.'s patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Zense-Life Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Zense-Life Inc.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Zense-life ranks #38,425 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#38,425
of 49,997 US assignees by volume: Top 27%
by Innovation Score (44.0/100): 17.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R38425 · US Corporation #38,425 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
LOWER-Q #38,425/49,997
PHOTO-FINISH Zebrafish Labs
CPC-NARROW A61B · 8 areas
INNOV-PAR 44.0/100
CLAIMS-RICH 17.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Zebrafish Labs, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Zense-life’s 44.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (16%) Velocity 16.7 pts (38%) Breadth 10.0 pts (23%) Claim depth 10.2 pts (23%)

Qualcomm Incorporated · highest

85
Zense-Life · this assignee

44
3D Lighting… · lowest

7

What this shows Zense-life's Innovation Score is 44.0/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Zense-life?

Each dot is one of Zense-life’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zense-life’s own 17.0 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Zense-life vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Zense-life's grants concentrate

Zense-Life Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (3 grants) versus a trough of 2 in 2021. By volume, Zense-life sits between Zsquare Ltd. and ZetrOZ, Inc..

Zense-life's three-year grant acceleration

Zense-Life Inc. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Zsquare

7
ZST Holdings

7
Zummo Innovacione…

7
Zebrafish Labs

7
Zep Solar

7
Zepto Life Techno…

7
Zetec

7
Zetroz

7
Zense-life ◀

7

What this shows Zense-Life holds 7 patents at rank #38,422, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Zense-Life

By rank, the assignees closest to #38,422 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Zense-Life's primary technology class.

Zense-life's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Zense-Life Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	28.6%
2022	3	42.9%
2023	2	28.6%

Which technologies does Zense-Life Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 7

C12Y - Enzymes 4

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

C25D - Processes FOR THE Electrolytic OR Electrophoretic Production OF COATINGS; ELECTROFORMING; Apparatus Therefor 4

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Zense-Life Inc.'s patent record in context - here's where to go next.

Zense-Life Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #38,425 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Zense-Life Inc. against Zsquare Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.